Clinical Trials Directory

Trials / Conditions / Diphtheria-Tetanus-acellular Pertussis Vaccines

Diphtheria-Tetanus-acellular Pertussis Vaccines

8 registered clinical trials studyying Diphtheria-Tetanus-acellular Pertussis Vaccines.

StatusTrialSponsorPhase
CompletedImmune Response followingTdap Vaccine in Pregnancy
NCT04082299
Hillel Yaffe Medical Center—
CompletedEvaluation of Immunogenicity, Safety and Reactogenicity of GSK Biologicals' Boostrix Vaccine Administered as a
NCT03311659
GlaxoSmithKlinePhase 3
CompletedImmunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Pregnant Women
NCT02377349
GlaxoSmithKlinePhase 4
CompletedImpact of Boostrix™ Maternal Vaccination on Morbidity and Mortality of Pertussis Disease in Infants ≤6 Weeks o
NCT02569879
GlaxoSmithKline—
CompletedPost-marketing Surveillance to Assess the Safety of Boostrix Vaccine Given According to Prescribing Informatio
NCT01929291
GlaxoSmithKline—
CompletedPost-marketing Surveillance to Assess the Safety of Infanrix-IPV Vaccine Among Infants and Children in Korea
NCT01568060
GlaxoSmithKline—
CompletedEvaluation of GlaxoSmithKline Biologicals' Boostrix® Vaccine in Comparison With Decavac™ Vaccine.
NCT00835237
GlaxoSmithKlinePhase 3
CompletedImmunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination in Study NCT01267058
NCT00548171
GlaxoSmithKlinePhase 4